1 min listen
Trabectedin for recurrent grade 2 or 3 meningiomas
Trabectedin for recurrent grade 2 or 3 meningiomas
ratings:
Length:
17 minutes
Released:
Jan 28, 2022
Format:
Podcast episode
Description
Dr. Iyad Alnahhas interviews Dr. Matthias Preusser about the recent manuscript entitled: "Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG)", published online in Neuro-Oncology in October 2021.
Released:
Jan 28, 2022
Format:
Podcast episode
Titles in the series (79)
Announcing Neuro-Oncology: The Podcast: Announcing Neuro-Oncology: The Podcast by Neuro-Oncology: The Podcast